98 related articles for article (PubMed ID: 17208268)
1. Incorporation of chimeric HIV-SIV-Env and modified HIV-Env proteins into HIV pseudovirions.
Devitt G; Emerson V; Holtkotte D; Pfeiffer T; Pisch T; Bosch V
Virology; 2007 May; 361(2):465-71. PubMed ID: 17208268
[TBL] [Abstract][Full Text] [Related]
2. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
3. Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system.
Yamshchikov GV; Ritter GD; Vey M; Compans RW
Virology; 1995 Dec; 214(1):50-8. PubMed ID: 8525638
[TBL] [Abstract][Full Text] [Related]
4. Domains in the simian immunodeficiency virus gp41 cytoplasmic tail required for envelope incorporation into particles.
Celma CC; Manrique JM; Affranchino JL; Hunter E; González SA
Virology; 2001 May; 283(2):253-61. PubMed ID: 11336550
[TBL] [Abstract][Full Text] [Related]
5. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
Chen P; Hübner W; Riviere K; Liu YX; Chen BK
Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
[TBL] [Abstract][Full Text] [Related]
6. In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein.
Manrique JM; Affranchino JL; González SA
Virology; 2008 May; 374(2):273-9. PubMed ID: 18255119
[TBL] [Abstract][Full Text] [Related]
7. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
Ritter GD; Mulligan MJ; Lydy SL; Compans RW
Virology; 1993 Nov; 197(1):255-64. PubMed ID: 8212561
[TBL] [Abstract][Full Text] [Related]
8. Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.
Vzorov AN; Compans RW
J Virol; 2000 Sep; 74(18):8219-25. PubMed ID: 10954518
[TBL] [Abstract][Full Text] [Related]
9. Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains.
Vzorov AN; Compans RW
Virology; 1996 Jul; 221(1):22-33. PubMed ID: 8661411
[TBL] [Abstract][Full Text] [Related]
10. Small variations in the length of the cytoplasmic domain of the simian immunodeficiency virus transmembrane protein drastically affect envelope incorporation and virus entry.
Manrique JM; Celma CC; Affranchino JL; Hunter E; González SA
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1615-24. PubMed ID: 11779349
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of simian--human immunodeficiency virus-like particles.
Yao Q; Kuhlmann FM; Eller R; Compans RW; Chen C
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):227-36. PubMed ID: 10710211
[TBL] [Abstract][Full Text] [Related]
12. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling.
Raviv Y; Viard M; Bess J; Blumenthal R
Virology; 2002 Feb; 293(2):243-51. PubMed ID: 11886244
[TBL] [Abstract][Full Text] [Related]
14. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the exposure of induced HIV glycoprotein epitopes in a potential HIV pseudovirion vaccine.
Devitt G; Emerson V; Pisch T; Keppler OT; Bosch V
Vaccine; 2007 Mar; 25(12):2161-7. PubMed ID: 17241712
[TBL] [Abstract][Full Text] [Related]
16. Functional relationship between the matrix proteins of feline and simian immunodeficiency viruses.
Manrique ML; González SA; Affranchino JL
Virology; 2004 Nov; 329(1):157-67. PubMed ID: 15476883
[TBL] [Abstract][Full Text] [Related]
17. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
[TBL] [Abstract][Full Text] [Related]
18. The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
Herrera C; Klasse PJ; Michael E; Kake S; Barnes K; Kibler CW; Campbell-Gardener L; Si Z; Sodroski J; Moore JP; Beddows S
Virology; 2005 Jul; 338(1):154-72. PubMed ID: 15932765
[TBL] [Abstract][Full Text] [Related]
19. Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection.
Okuma K; Boritz E; Walker J; Sarkar A; Alexander L; Rose JK
Virology; 2006 Mar; 346(1):86-97. PubMed ID: 16325218
[TBL] [Abstract][Full Text] [Related]
20. Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.
Bahbouhi B; Chazal N; Seidah NG; Chiva C; Kogan M; Albericio F; Giralt E; Bahraoui E
Biochem J; 2002 Sep; 366(Pt 3):863-72. PubMed ID: 12071862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
